Aurora Cannabis Inc.

TSX:ACB.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$6.31 +0.48%

+$0.02 today

Market cap
$414.85M
Beta
1.34
P/E (TTM)
-3.2
EPS (TTM)
-$1.31
52W Low $3.77High $9.33

Volume 0.32M

Average 0.42M

ACB.TO Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Aurora Cannabis Inc.TSX: ACB.TO

Net Margin · Q4 FY2026 · quarter ended Mar 2026

Net margin narrows to -149.7%

Net margin was -149.7% in Q4 FY2026, down 122.6 pp from a year earlier. On a trailing-twelve-month basis it was -12.1%, down 12.6 pp year over year. Over 3 fiscal years it widened by 75.8 pp.

Context

  • Net margin widened in 2 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 4 analysts of -8.3% for the fiscal year ending Mar 2027, up from -38.0% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
-149.7%-151.6 pp QoQ
Last fiscal yearMar 2026
-38.0%-38.4 pp YoY
LTMMar 2026
-12.1%-12.6 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-122.6 pp-2.5 pp+120.1 pp
1 year-38.4 pp+29.7 pp+68.1 pp
3 years+75.8 pp+43.3 pp-32.4 pp
5 years+44.5 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2026
-38.0%
Year-over-year change
-38.4pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How ACB.TO compares with its peers on the latest reported figures

  • ACB.TO's LTM Mar 2026 net margin of -12.1% is the 4th highest of the 8 companies compared; the peer median is -17.2%.
  • Its year-over-year change of -12.6 pp is the 6th highest of 8, against a peer median of +4.2 pp.
  • Over three fiscal years its change of +75.8 pp compares with a peer median of +129.4 pp.
ACB.TO Competitors Peer median
Net Margin for ACB.TO and competitors
Company Period LTM level YoY 3-year change
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 202660.8% +37.4 pp-74.7 pp
XLY.TOAuxly Cannabis Group Inc.LTM Mar 202620.9% +4.2 pp+165.5 pp
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026-9.2% -17.9 pp—
ACB.TOAurora Cannabis Inc.LTM Mar 2026-12.1% -12.6 pp+75.8 pp
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026-17.2% +29.5 pp+1532.6 pp
TSND.TOTerrAscend Corp.LTM Mar 2026-31.2% -4.4 pp+93.3 pp
WEED.TOCanopy Growth CorporationLTM Mar 2026-84.8% +137.6 pp+891.3 pp
EDT.TOSpectral Medical Inc.LTM Mar 2026-1377.2% -288.2 pp-1276.3 pp
Peer median (excluding ACB.TO) -17.2%+4.2 pp+129.4 pp

Competitors are the stored peer set for ACB.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2022
Jun 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
FY2026
Mar 2026
Revenue221.34M233.29M270.28M343.29M320.59M
Cost of Revenue200.11M297.65M138.82M155.69M303.89M
Gross Profit21.23M(64.36M)131.46M187.61M16.7M
Gross Margin9.6%-27.6%48.6%54.6%5.2%
Research & Development10.39M6.56M3.57M3.68M4.02M
Selling, General & Admin188.99M183.4M156.88M166.47M173.5M
Operating Expenses252.67M189.96M177.91M182.66M179.5M
Depreciation & Amortization93.66M43.57M33.07M22.55M14.19M
EBITDA(1.55B)(210.74M)(12.34M)51.35M(162.79M)
EBITDA Margin-702.4%-90.3%-4.6%15.0%-50.8%
Operating Income(231.45M)(254.32M)(46.45M)4.95M(162.79M)
Operating Margin-104.6%-109.0%-17.2%1.4%-50.8%
Interest Income4.51M19M12.81M11.51M5.85M
Interest Expense71.81M39.46M14.19M8.42M1.81M
Other Income / Expenses(1.49B)(41.1M)(13.15M)15.43M106.27M
Income Before Tax(1.72B)(295.42M)(59.6M)20.38M(56.52M)
Pre-Tax Margin-777.1%-126.6%-22.1%5.9%-17.6%
Income Tax Expense(2.14M)(20.32M)(554K)4.62M2.1M
Net Income(1.72B)(265.33M)(69.33M)1.59M(121.76M)
Net Margin-776.0%-113.7%-25.6%0.5%-38.0%
EPS (Basic)(79.92)(8.17)(1.28)0.03(2.15)
EPS (Diluted)(79.92)(8.17)(1.28)0.03(2.15)
Weighted Avg Shares21.49M32.27M51.26M54.88M56.71M
Weighted Avg Shares (Diluted)21.49M32.27M51.26M55.75M56.71M

Aurora Cannabis Inc.

TSX:ACB.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.31

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.